Explanatory Notes

World Health Organization (WHO) core and complementary essential medicines lists 2019 were adapted in
preparing the SFDA essential medicines lists 2020.

The core essential medicines list presents a list of minimum medicine needs for a basic health-care system in
Saudi Arabia, listing the most efficacious, safe and cost–effective medicines for priority conditions.

The complementary essential medicines list [CL] presents essential medicines for priority diseases, for which
specialized diagnostic or monitoring facilities, and/or specialist medical care, and/or specialist training are need
In case of doubt, medicines may also be listed as complementary on the basis of consistent higher costs or less
attractive cost-effectiveness in a variety of settings.

In addition, alternative essential medicines [AL] that are registered in Saudi Food and Drug Authority were add
to the WHO listed essential medicine [WHO AL] as the example of the class for which there is the best evidenc
for effectiveness and safety. Alternatives were selected mainly based on Anatomical Therapeutic Chemical (ATC
Classification System developed by the WHO for the classification of drugs and other medical products.

Regardless of approved therapeutic indications of each alternative, listed alternatives in a red box are expected
provide some similarity in the clinical performance within a pharmacological class. Standard treatment guidelin
should be consulted for information on appropriate alternative essential medicine and dosage forms that are
generally available at the lowest price.

If you have any enquiries, suggestions or requests regarding the Essential Medicines List, please do not hesitate
to contact the National Drug and Poison Information Center via the following channels:

National Drug and Poison Information Center (NDPIC)

Drug Sector, Saudi Food and Drug Authority (SFDA)
4904 Northern Ring Road, Riyadh,
13513-7148 Saudi Arabia
Tel: 19999
[email protected]
2019 were adapted in

sic health-care system in

ty conditions.

iority diseases, for which

specialist training are needed.
sistent higher costs or less

d Drug Authority were added

h there is the best evidence
Therapeutic Chemical (ATC)
medical products.

s in a red box are expected to

andard treatment guidelines
nd dosage forms that are

List, please do not hesitate

ls:
 WHO Classification Essential medicines Dosage Forms

1. ANAESTHETICS,
PREOPERATIVE MEDICINES AND
MEDICAL GASES

1.1 General anaesthetics and oxygen

1.1.1 Inhalational medicines

halothane Inhalation.
isoflurane Inhalation.
nitrous oxide Inhalation.
oxygen Inhalation (medical gas).
1.1.2 Injectable medicines
Injection: 50 mg (as hydrochloride)/ mL in 10-
ketamine
mL vial.
propofol Injection: 10 mg/ mL; 20 mg/ mL.
thiopental Injection: 500 mg, 1000 mg
1.2 Local anaesthetics

Injection: 0.25%; 0.5% (hydrochloride) in vial.

Injection for spinal anaesthesia: 0.5%
bupivacaine
(hydrochloride) in 4- mL ampoule to be mixed
with 7.5% glucose solution.

Injection: 1%; 2% (hydrochloride) in vial.

Injection for spinal anaesthesia: 5%
lidocaine (hydrochloride) in 2- mL ampoule to be mixed
with 7.5% glucose solution.
Topical forms: 2% to 4% (hydrochloride).

mepivacaine Injection: 3%
cinchocaine Topical forms: 1 %
ropivacaine Injection: 2%, 7.5%, 10%

Dental cartridge: 2% (hydrochloride) +

epinephrine 1:80 000.
lidocaine + epinephrine (adrenaline)
Injection: 1%; 2% (hydrochloride or sulfate) +
epinephrine 1:200 000 in vial.

Injection: 30 mg (hydrochloride)/ mL in 1- mL
ephedrine
ampoule.

1.3 Preoperative medication and sedation

for short-term procedures

atropine Injection: 1 mg (sulfate) in 1- mL ampoule.

Injection: 1 mg/ mL.

midazolam
Oral liquid: 2 mg/ mL . Tablet: 7.5 mg; 15 mg.

Oral liquid: 0.4 mg/ml.

diazepam Injection: 5 mg/ml.
Tablet: 2 mg, 5 mg.
lorazepam Tablet: 1 mg, 2 mg.
Injection: 10 mg (sulfate or hydrochloride) in 1-
morphine
mL ampoule.
1.4 Medical gases
Inhalation
oxygen
2. MEDICINES FOR PAIN AND
PALLIATIVE CARE

2.1 Non-opioids and non-steroidal anti-

inflammatory medicines (NSAIMs)

Suppository: 50 mg to 150 mg.

acetylsalicylic acid
Tablet: 100 mg to 500 mg.
Oral liquid: 200 mg/5 mL.
ibuprofen
Tablet: 200 mg; 400 mg; 600 mg.
Oral liquid: 120 mg/5 mL; 125 mg/5 mL.
paracetamol Suppository: 100 mg.
Tablet: 100 mg to 500 mg.
2.2 Opioid analgesics
codeine Tablet: 30 mg (phosphate).
Transdermal patch: 12 micrograms/hr;
fentanyl 25 micrograms/hr; 50 micrograms/hr;
75 micrograms/hr; 100 micrograms/hr

Granules (slow-release; to mix with water): 20

mg –200 mg (morphine sulfate).
Injection: 10 mg (morphine hydrochloride or
morphine sulfate) in 1- mL ampoule.
Oral liquid: 10 mg (morphine hydrochloride or
morphine morphine sulfate)/5 mL.
Tablet (slow release): 10 mg–200mg (morphine
hydrochloride or morphine sulfate).
Tablet (immediate release): 10 mg (morphine
sulfate).

Tablets (prolonged – release): 8 mg, 16 mg, 32

hydromorphone
mg, 64 mg.
Tablet (controlled release) : 10 mg, 15 mg, 20
oxycodone
mg, 30 mg, 40mg, 50mg

Tablet: 5 mg; 10 mg (as hydrochloride)

Oral liquid: 5mg/ 5mL; 10mg/ 5mL (as
methadone hydrochloride)
Concentrate for oral liquid: 5 mg/ mL; 10mg/
mL (as hydrochloride)

2.3 Medicines for other common

symptoms in palliative care
amitriptyline Tablet: 10 mg; 25 mg; 75 mg.
Injection: 50 mg/ mL.
cyclizine
Tablet: 50 mg.

Injection: 4 mg/ mL in 1- mL ampoule (as

dexamethasone disodium phosphate salt).
Oral liquid: 2 mg/5 mL. Tablet: 2 mg ; 4 mg.

Injection: 5 mg/ mL.

Oral liquid: 2 mg/5 mL.
diazepam
Rectal solution: 2.5 mg; 5 mg; 10 mg.
Tablet: 5 mg; 10 mg.

Capsule: 100 mg.

docusate sodium
Oral liquid: 50 mg/5 mL.
Solid oral dosage form: 20 mg (as
fluoxetine hydrochloride).
 Injection: 5 mg in 1‐ mL ampoule.
haloperidol Oral liquid: 2 mg/ mL.
Solid oral dosage form: 0.5 mg; 2mg; 5 mg.

hyoscine butylbromide Injection: 20 mg/ mL.

Injection: 400 micrograms/ mL; 600
hyoscine hydrobromide micrograms/ mL.
Transdermal patches: 1 mg/72 hours.
lactulose Oral liquid: 3.1–3.7 g/5 mL.
loperamide Solid oral dosage form: 2 mg.
Injection: 5 mg (hydrochloride)/mL in 2‐mL
ampoule. Oral
metoclopramide
liquid: 5 mg/5 mL.
Solid oral form: 10 mg (hydrochloride).

Injection: 1 mg/ mL; 5 mg/ mL.

midazolam Solid oral dosage form: 7.5 mg; 15 mg.
Oral liquid: 2mg/ mL .

Injection: 2 mg base/ mL in 2- mL ampoule (as

hydrochloride).
ondansetron Oral liquid: 4 mg base/5 mL.
Solid oral dosage form: Eq 4 mg base; Eq 8 mg
base.

palonosetron Injection: 0.05 mg/ml.

granisetron Injection: 1 mg/ml.
senna Oral liquid: 7.5 mg/5 mL.
3. ANTIALLERGICS AND
MEDICINES USED IN
ANAPHYLAXIS
Injection: 4 mg/ mL in 1- mL ampoule (as
dexamethasone
disodium phosphate salt).
Injection: 1 mg (as hydrochloride or hydrogen
epinephrine (adrenaline)
tartrate) in 1- mL ampoule.
Powder for injection: 100 mg (as sodium
hydrocortisone
succinate) in vial.
loratadine Oral liquid: 1 mg/ mL. Tablet: 10 mg.
Injection: 10 mg/ml.
chlorphenamine Oral liquid: 0.4 mg/ml, 0.5 mg/ml.
Tablet: 4 mg.
diphenhydramine Oral liquids.
cetirizine Tablet: 5 mg, 10 mg.
fexofenadine Oral liquid: 1 mg/ml.
Oral liquid: 5 mg/ mL .
prednisolone
Tablet: 5 mg; 25 mg.
Injection: 4 mg/ml.
betamethasone
Tablet: 0.5 mg.

Injection: 40 /mg/ml, 125 mg, 500 mg, 1000 mg.

methylprednisolone
Tablet: 4 mg.

prednisone Tablet: 10 mg, 20 mg

4. ANTIDOTES AND OTHER
SUBSTANCES USED IN
POISONINGS
4.1 Non-specific
charcoal, activated Powder.
4.2 Specific

Injection: 200 mg/ mL in 10- mL ampoule.

acetylcysteine
Oral liquid: 10% ; 20% .
 atropine Injection: 1 mg (sulfate) in 1- mL ampoule.

calcium gluconate Injection: 100 mg/ mL in 10- mL ampoule.

methylthioninium chloride
Injection: 10 mg/ mL in 10- mL ampoule.
(methylene blue)
Injection: 400 micrograms (hydrochloride) in 1-
naloxone
mL ampoule.
penicillamine Solid oral dosage form: 250 mg.

potassium ferric hexacyano-

Powder for oral administration.
ferrate(ii) - 2h2o(prussian blue)

sodium nitrite Injection: 30 mg/ mL in 10- mL ampoule.

sodium thiosulfate Injection: 250 mg/ mL in 50- mL ampoule.

deferoxamine Powder for injection: 500 mg (mesilate) in vial.

dimercaprol Injection in oil: 50 mg/ mL in 2- mL ampoule.

Injection: 5 mg/ mL (sulfate) in 20- mL ampoule

fomepizole
or 1 g/ mL (base) in 1.5- mL ampoule.

sodium calcium edetate Injection: 200 mg/ mL in 5- mL ampoule.

succimer Solid oral dosage form: 100 mg.

5. ANTICONVULSANTS/
ANTIEPILEPTICS
Oral liquid: 100 mg/5 mL.
carbamazepine Tablet (chewable): 100 mg; 200 mg.
Tablet (scored): 100 mg; 200 mg.
Gel or rectal solution: 5 mg/ mL in 0.5 mL; 2-
diazepam
mL; 4- mL tubes.

Tablet: 25 mg; 50 mg; 100 mg; 200 mg.

Tablet (chewable, dispersible): 2 mg; 5 mg; 25
lamotrigine
mg; 50 mg; 100 mg; 200 mg.

Parenteral formulation: 2 mg/ mL in 1- mL

lorazepam
ampoule; 4 mg/ mL in 1- mL ampoule.

Injection: 0.5g/ mL in 2- mL ampoule

(equivalent to 1 g in 2 mL; 50% weight/volume);
0.5g/ mL in
magnesium sulfate
10- mL ampoule (equivalent to 5 g in 10 mL;
50% weight/volume).

Solution for oromucosal administration:

5mg/mL; 10 mg/mL
Ampoule*: 1 mg/ mL; 10 mg/mL
midazolam
*for buccal administration when solution for
oromucosal administration is not available

Injection: 200 mg/ mL (sodium).

phenobarbital Oral liquid: 15 mg/5 mL.
Tablet: 15 mg to 100 mg.
 Injection: 50 mg/ mL in 5- mL vial (sodium
salt). Oral
liquid: 25 mg to 30 mg/5 mL.*
Solid oral dosage form: 25 mg; 50 mg; 100 mg
(sodium salt). Tablet
phenytoin (chewable): 50 mg. * The
presence of both 25 mg/5 mL and 30 mg/5 mL
strengths on the same market would cause
confusion in prescribing and dispensing and
should be avoided.

Oral liquid: 200 mg/5 mL.

Tablet (crushable): 100 mg.
valproic acid (sodium valproate)
Tablet (enteric-coated): 200 mg; 500 mg
(sodium valproate).

Capsule: 250 mg.

ethosuximide
Oral liquid: 250 mg/5 mL.

Injection: 100 mg/ mL in 4- mL ampoule; 100

valproic acid (sodium valproate)
mg/ mL in 10- mL ampoule.

6. ANTI-INFECTIVE MEDICINES

6.1 Anthelminthics
6.1.1 Intestinal anthelminthics
albendazole Tablet (chewable): 400 mg.
ivermectin Tablet (scored): 3 mg.

levamisole Tablet: 50 mg; 150 mg (as hydrochloride).

mebendazole Tablet (chewable): 100 mg; 500 mg.

niclosamide Tablet (chewable): 500 mg.
praziquantel Tablet: 150 mg; 600 mg.
Oral liquid: 50 mg (as embonate or pamoate)/
mL.
pyrantel
Tablet (chewable): 250 mg (as embonate or
pamoate).
6.1.2 Antifilarials
albendazole Tablet (chewable): 400 mg.

diethylcarbamazine Tablet: 50 mg; 100 mg (dihydrogen citrate).

ivermectin Tablet (scored): 3 mg.

6.1.3 Antischistosomals and other
antitrematode medicines
praziquantel Tablet: 600 mg.
triclabendazole Tablet: 250 mg.
Capsule: 250 mg.
oxamniquine Oral liquid: 250 mg/5 mL.

6.2 Antibacterials
6.2.1 Access group antibiotics

amikacin Injection: 250 mg (as sulfate)/mL in 2- mL vial

Powder for oral liquid: 125 mg (as trihydrate)/5

mL; 250 mg (as trihydrate)/5 mL .
Solid oral dosage form: 250 mg; 500 mg (as
amoxicillin
trihydrate).
Powder for injection: 250 mg; 500 mg; 1 g (as
sodium) in vial.
 Oral liquid: 125 mg amoxicillin + 31.25 mg
clavulanic acid/5 mL AND 250 mg amoxicillin
+ 62.5 mg clavulanic acid/5 mL .
Tablet: 500 mg (as trihydrate) + 125 mg (as
amoxicillin + clavulanic acid
potassium salt).
Powder for injection: 500 mg (as sodium) +
100 mg (as potassium salt); 1000 mg (as
sodium) + 200 mg (as potassium salt) in vial.

Powder for injection: 500 mg; 1 g (as sodium

ampicillin
salt) in vial.

Powder for injection: 900 mg benzylpenicillin (=

1.2 million IU) in 5- mL vial ;
benzathine benzylpenicillin
1.44 g benzylpenicillin (= 2.4 million IU) in 5-
mL vial.

Powder for injection: 600 mg (= 1 million IU); 3

benzylpenicillin g (= 5 million IU) (sodium or potassium salt) in
vial.

Powder for reconstitution with water: 125 mg/5

mL; 250 mg/5 mL (anhydrous).
cefalexin
Solid oral dosage form: 250 mg (as
monohydrate).

Powder for injection: 1 g (as sodium salt) in vial.

cefazolin

Capsule: 250 mg.

Oily suspension for injection*: 0.5 g (as sodium
succinate)/ mL in 2- mL ampoule.
Oral liquid: 150 mg (as palmitate)/5 mL.
chloramphenicol Powder for injection: 1 g (sodium succinate) in
vial. *
Only for the presumptive treatment of epidemic
meningitis in children older than 2 years and in
adults.

Capsule: 150 mg (as hydrochloride).

clindamycin Injection: 150 mg (as phosphate)/ mL.
Oral liquid: 75 mg/5 mL (as palmitate) .

Capsule: 500 mg; 1 g (as sodium salt).

Powder for injection: 500 mg (as sodium salt) in
cloxacillin
vial. Powder
for oral liquid: 125 mg (as sodium salt)/5 mL.

Capsule: 250 mg; 500 mg.

Powder for injection: 250 mg in vial.
flucloxacillin
Powder for oral liquid: 25 mg /5 mL; 50 mg /5
mL.

Oral liquid: 25 mg/5 mL ; 50 mg/5 mL

(anhydrous) . Solid
doxycycline oral dosage form: 50 mg ; 100 mg (as hyclate).
Powder for injection: 100 mg in vial

Injection: 10 mg; 40 mg (as sulfate)/ mL in 2-

gentamicin
mL vial.
 Injection: 500 mg in 100- mL vial.
Oral liquid: 200 mg (as benzoate)/5 mL.
metronidazole
Suppository: 500 mg; 1 g.
Tablet: 200 mg to 500 mg.

Oral liquid: 25 mg/5 mL .

nitrofurantoin
Tablet: 100 mg.
Powder for oral liquid: 250 mg (as potassium
phenoxymethylpenicillin salt)/5 mL.
Tablet: 250 mg (as potassium salt).

Powder for injection: 1 g (=1 million IU); 3 g

procaine benzylpenicillin (=3 million IU) in vial.

Powder for injection: 2 g (as hydrochloride) in

spectinomycin
vial.

Injection:
80 mg + 16 mg/ mL in 5- mL ampoule; 80 mg +
16 mg/ mL in 10- mL ampoule.
sulfamethoxazole + trimethoprim Oral liquid: 200 mg + 40 mg/5 mL.
Tablet: 100 mg + 20 mg; 400 mg + 80 mg; 800
mg + 160 mg.

6.2.2 Watch group antibiotics

Capsule: 250 mg; 500 mg (anhydrous).
azithromycin Oral liquid: 200 mg/5 mL.

Capsule or tablet: 200 mg; 400 mg (as

cefixime trihydrate).
Powder for oral liquid: 100 mg /5 mL

Powder for injection: 250 mg per vial (as sodium

cefotaxime salt)

Powder for injection: 250 mg; 1 g (as sodium

ceftriaxone salt) in vial.

Powder for injection: 250 mg, 750 mg, 1.5 g (as

cefuroxime
sodium salt) in vial

Oral liquid: 250 mg/5 mL (anhydrous) .

ciprofloxacin Solution for IV infusion: 2 mg/ mL (as hyclate).
Tablet: 250 mg (as hydrochloride).

Solid oral dosage form: 500 mg.

Powder for oral liquid: 125 mg/5 mL; 250 mg/5
clarithromycin mL Powder
for injection: 500 mg in vial

Powder for injection: 2 g (as sodium salt) + 250

piperacillin + tazobactam mg (as sodium salt); 4 g (as sodium salt) + 500
mg (as sodium salt) in vial

vancomycin Capsule: 125 mg; 250 mg (as hydrochloride).

Powder for injection: 250 mg or 1 g (as

ceftazidime
pentahydrate) in vial.
Powder for injection: 500 mg (as trihydrate); 1
meropenem g (as trihydrate) in vial

Powder for injection: 250 mg (as hydrochloride)

vancomycin
in vial.
6.2.3 Reserve group antibiotics
 ceftazidime + avibactam Powder for injection: 2 g + 0.5 g in vial

Powder for injection: 1 million I.U. (as

colistin
colistemethate sodium) in vial
Powder for injection: 2 g; 4 g (as sodium) in
fosfomycin
vial

Injection for intravenous administration: 2 mg/

mL in 300 mL bag. Powder
linezolid
for oral liquid: 100 mg/5 mL.
Tablet: 400 mg; 600 mg.

meropenem + vaborbactam Powder for injection: 2 g + 2 g in vial

plazomicin Injection: 500 mg/10 mL

polymyxin b Powder for injection: 500,000 I.U. in vial

6.2.4 Antileprosy medicines

clofazimine Capsule: 50 mg; 100 mg.
dapsone Tablet: 25 mg; 50 mg; 100 mg.

rifampicin Solid oral dosage form: 150 mg; 300 mg.

6.2.5 Antituberculosis medicines

Oral liquid: 25 mg/ mL .

ethambutol Tablet: 100 mg to 400 mg (hydrochloride).
Tablet (dispersible): 100 mg

ethambutol + isoniazid +
Tablet: 275 mg + 75 mg + 400 mg + 150 mg.
pyrazinamide + rifampicin

ethambutol + isoniazid + rifampicin Tablet: 275 mg + 75 mg + 150 mg.

Oral liquid: 50 mg/5 mL

Tablet: 100 mg to 300 mg. Tablet
isoniazid
(scored): 50 mg.
Tablet (dispersible): 100 mg

isoniazid + pyrazinamide + Tablet: 75 mg + 400 mg + 150 mg.

rifampicin Tablet (dispersible): 50 mg + 150 mg + 75 mg .

Tablet: 75 mg + 150 mg; 150 mg + 300 mg.

isoniazid + rifampicin
Tablet (dispersible): 50 mg + 75 mg .

Oral liquid: 30 mg/ mL .

Tablet: 400 mg.
pyrazinamide
Tablet (dispersible): 150 mg.
Tablet (scored): 150 mg.
rifabutin Solid oral dosage form: 150 mg.

Oral liquid: 20 mg/ mL .

rifampicin
Solid oral dosage form: 150 mg; 300 mg.

rifapentine Tablet: 150 mg

Powder for injection: 100 mg; 500 mg; 1 g (as
amikacin
sulfate) in vial.

Oral liquid: 125 mg amoxicillin + 31.25 mg

clavulanic acid/5 mL; 250 mg amoxicillin +
62.5 mg clavulanic acid/5 mL .
amoxicillin + clavulanic acid
Tablet: 500 mg (as trihydrate) + 125 mg (as
potassium salt).

bedaquiline Tablet: 100 mg.

 clofazimine Solid oral dosage form: 50 mg; 100 mg.

cycloserine Solid oral dosage form: 125 mg ; 250 mg.

delamanid Tablet: 50 mg.

Tablet: 125 mg; 250 mg. Tablet
ethionamide
(dispersible): 125 mg
Tablet: 250mg; 500 mg; 750 mg.
levofloxacin
Tablet (dispersible): 100 mg

Injection for intravenous administration: 2 mg/

mL in 300 mL bag. Powder
linezolid for oral liquid: 100 mg/5 mL.
Tablet: 400 mg; 600 mg.
Tablet (dispersible): 150 mg

Powder for injection: 500 mg (as trihydrate); 1

meropenem
g (as trihydrate) in vial
Tablet: 400 mg.
moxifloxacin
Tablet (dispersible): 100 mg
Granules: 4 g in sachet.
p-aminosalicylic acid
Tablet: 500 mg.

streptomycin Powder for injection: 1 g (as sulfate) in vial.

6.3 Antifungal medicines

Powder for injection: 50 mg in vial (as sodium

amphotericin b
deoxycholate or liposomal complex).

Vaginal cream: 1%; 10%.

clotrimazole
Vaginal tablet: 100 mg; 500 mg.
Capsule: 50 mg. Injection:
fluconazole 2 mg/ mL in vial.
Oral liquid: 50 mg/5 mL.
Capsule: 250 mg.
flucytosine
Infusion: 2.5 g in 250 mL.

Oral liquid: 125 mg/5 mL .

griseofulvin
Solid oral dosage form: 125 mg; 250 mg.

Capsule: 100 mg. Oral

itraconazole
liquid: 10 mg/mL.

Lozenge: 100 000 IU.

Oral liquid: 50 mg/5 mL ; 100 000 IU/ mL .
nystatin
Pessary: 100 000 IU.
Tablet: 100 000 IU; 500 000 IU.

Tablet: 50 mg; 200 mg

voriconazole Powder for injection: 200 mg in vial
Powder for oral liquid: 40 mg/mL
potassium iodide Saturated solution.
6.4 Antiviral medicines
6.4.1 Antiherpes medicines

Oral liquid: 200 mg/5 mL .

Powder for injection: 250 mg (as sodium salt) in
aciclovir
vial.
Tablet: 200 mg.
famciclovir Tablet: 125 mg , 250 mg
valaciclovir Tablet: 500mg
6.4.2 Antiretrovirals
6.4.2.1 Nucleoside/Nucleotide reverse
transcriptase inhibitors
 Tablet: 300 mg (as sulfate).
abacavir (abc)
Tablet (dispersible, scored): 60 mg (as sulfate).

Oral liquid: 50 mg/5 mL.

lamivudine (3tc)
Tablet: 150 mg.

Tablet: 300 mg (tenofovir disoproxil fumarate –

tenofovir disoproxil fumarate (tdf)
equivalent to 245 mg tenofovir disoproxil).

Capsule: 250 mg.

Oral liquid: 50 mg/5 mL.
zidovudine (zdv or azt) Solution for IV infusion injection: 10 mg/ mL in
20- mL vial.
Tablet: 300 mg.

6.4.2.2 Non-nucleoside reverse

transcriptase inhibitors
efavirenz (efv or efz) Tablet: 200 mg (scored); 600 mg.
Oral liquid: 50 mg/5 mL.
nevirapine (nvp)
Tablet: 50 mg (dispersible); 200 mg.
6.4.2.3 Protease inhibitors
Solid oral dosage form: 100 mg; 300 mg (as
atazanavir
sulfate).
Tablet (heat stable): 300 mg (as sulfate) + 100
atazanavir + ritonavir
mg.

darunavir Tablet: 75 mg; 400 mg; 600 mg; 800 mg

Oral liquid: 400 mg + 100 mg/5 mL.

Tablet (heat stable): 100 mg + 25 mg; 200 mg +
lopinavir + ritonavir (lpv/r)
50 mg.
Solid oral dosage form: 40 mg + 10 mg .

Oral liquid: 400 mg/5 mL.

ritonavir Tablet (heat stable): 25 mg; 100 mg. Oral
powder: 100 mg in sachet .
6.4.2.4 Integrase inhibitors
dolutegravir Tablet: 50 mg

Tablet (chewable): 25 mg; 100 mg.

raltegravir Tablet: 400 mg
Granules for oral suspension: 100 mg in sachet

FIXED-DOSE COMBINATIONS
Tablet (dispersible, scored): 120 mg (as sulfate)
abacavir + lamivudine
+ 60 mg.
Tablet: 50 mg + 300 mg + 300 mg (disoproxil
dolutegravir + lamivudine +
fumarate equivalent to 245 mg tenofovir
tenofovir
disoproxil)

Tablet: 600 mg + 200 mg + 300 mg (disoproxil

efavirenz + emtricitabine +
fumarate equivalent to 245 mg tenofovir
tenofovir
disoproxil).

Tablet: 400 mg + 300 mg + 300 mg (disoproxil

efavirenz + lamivudine + tenofovir fumarate equivalent to 245 mg tenofovir
disoproxil)

Tablet: 200 mg + 300 mg (disoproxil fumarate

emtricitabine + tenofovir
equivalent to 245 mg tenofovir disoproxil).

lamivudine + nevirapine + Tablet: 30 mg + 50 mg + 60 mg ; 150 mg + 200

zidovudine mg + 300 mg.

lamivudine + zidovudine Tablet: 30 mg + 60 mg ; 150 mg + 300 mg.

6.4.2.5 Medicines for prevention of HIV-
related opportunistic infections

isoniazid + pyridoxine + Tablet (scored): 300 mg + 25 mg + 800 mg +

sulfamethoxazole + trimethoprim 160 mg

6.4.3 Other antivirals

Injection for intravenous administration: 800 mg

and 1 g in 10- mL phosphate buffer solution.
ribavirin
Solid oral dosage form: 200 mg; 400 mg; 600
mg.

valganciclovir Tablet: 450 mg.

Capsule: 30 mg; 45 mg; 75 mg (as phosphate).
oseltamivir
Oral powder: 12 mg/ mL.
Powder for oral solution: 50 mg/mL Tablet:
valganciclovir
450 mg.
6.4.4 Antihepatitis medicines
6.4.4.1 Medicines for hepatitis B
6.4.4.1.1 Nucleoside/Nucleotide reverse
transcriptase inhibitors
Oral liquid: 0.05 mg/ mL
entecavir
Tablet: 0.5 mg; 1 mg

Tablet: 300 mg (tenofovir disoproxil fumarate –

tenofovir disoproxil fumarate (tdf)
equivalent to 245 mg tenofovir disoproxil).

6.4.4.2 Medicines for hepatitis C

6.4.4.2.1 □ Pangenotypic direct-acting
antiviral combinations

daclatasvir Tablet: 30 mg; 60 mg (as hydrochloride)

glecaprevir + pibrentasvir Tablet: 100 mg + 40 mg

sofosbuvir Tablet: 400 mg
sofosbuvir + velpatasvir Tablet: 400 mg + 100 mg

6.4.4.2.2 Non-pangenotypic direct-acting

antiviral combinations

dasabuvir Tablet: 250 mg

ledipasvir + sofosbuvir Tablet: 90 mg + 400 mg.

ombitasvir + paritaprevir + ritonavir Tablet: 12.5 mg + 75 mg + 50 mg

6.4.4.2.3 Other antivirals for hepatitis C

Injection for intravenous administration: 800 mg

and 1 g in 10- mL phosphate buffer solution.
ribavirin
Solid oral dosage form: 200 mg; 400 mg; 600
mg.

Vial or prefilled syringe:

180 micrograms (peginterferon alfa-2a),
pegylated interferon alfa (2a or 2b)
80 microgram, 100 microgram (peginterferon
alfa-2b).

6.5 Antiprotozoal medicines

6.5.1 Antiamoebic and antigiardiasis
medicines
diloxanide Tablet: 500 mg (furoate).
 Injection: 500 mg in 100- mL vial.
metronidazole Oral liquid: 200 mg (as benzoate)/5 mL.
Tablet: 200 mg to 500 mg.

ornidazole Tablet: 500 mg.

tinidazole Tablet: 500 mg.
secnidazole Tablet: 500 mg.

6.5.2 Antileishmaniasis medicines

Powder for injection: 50 mg in vial (as sodium

amphotericin b
deoxycholate or liposomal complex).

miltefosine Solid oral dosage form: 10 mg; 50 mg.

Solution for intramuscular injection: 750 mg of

paromomycin
paromomycin base (as the sulfate).

Injection: 100 mg/ mL, 1 vial = 30 mL or 30%,

sodium stibogluconate or
equivalent to approximately 8.1% antimony
meglumine antimoniate
(pentavalent) in 5- mL ampoule.

6.5.3 Antimalarial medicines

6.5.3.1 For curative treatment

amodiaquine Tablet: 153 mg or 200 mg (as hydrochloride).

artemether Oily injection: 80 mg/ mL in 1- mL ampoule.

Tablet: 20 mg + 120 mg.

artemether + lumefantrine
Tablet (dispersible): 20 mg + 120 mg .

Injection: ampoules, containing 60 mg

anhydrous artesunic acid with a separate
ampoule of 5% sodium bicarbonate solution.
For use in the management of severe malaria.
artesunate Rectal dosage form: 50 mg ; 100 mg ; 200 mg
capsules (for pre-referral treatment of severe
malaria only; patients should be taken to an
appropriate health facility for follow-up care) .
Tablet: 50 mg.

Tablet: 25 mg + 67.5 mg; 50 mg + 135 mg; 100

mg + 270 mg. *
Other combinations that deliver the target doses
artesunate + amodiaquine*
required such as 153 mg or 200 mg (as
hydrochloride) with 50 mg artesunate can be
alternatives.

artesunate + mefloquine Tablet: 25 mg + 55 mg; 100 mg + 220 mg.

artesunate + pyronaridine Tablet: 60 mg + 180 mg

tetraphosphate Granules: 20 mg + 60 mg .

Oral liquid: 50 mg (as phosphate or sulfate)/5

chloroquine
mL. Tablet:
100 mg; 150 mg (as phosphate or sulfate).

dihydroartemisinin + piperaquine
Tablet: 20 mg + 160 mg; 40 mg + 320 mg
phosphate
 Capsule: 100 mg (as hydrochloride or hyclate).
doxycycline
Tablet (dispersible): 100 mg (as monohydrate).

mefloquine Tablet: 250mg (as hydrochloride)

primaquine Tablet: 7.5 mg; 15 mg (as diphosphate).

Injection: 300 mg quinine hydrochloride/ mL in

2- mL ampoule. Tablet:
quinine
300 mg (quinine sulfate) or 300 mg (quinine
bisulfate).
sulfadoxine + pyrimethamine Tablet: 500 mg + 25 mg.
6.5.3.2 For chemoprevention

Co-packaged dispersible tablets:

amodiaquine 76.5 mg (as hydrochloride) [3] and
sulfadoxine + pyrimethamine 250 mg + 12.5 mg
amodiaquine – sulfadoxine +
[1];
pyrimethamine
amodiaquine 153 mg (as hydrochloride) [3] and
sulfadoxine + pyrimethamine 500 mg + 25 mg
[1];

Oral liquid: 50 mg (as phosphate or sulfate)/5

mL.
chloroquine
Tablet: 100mg; 150 mg (as phosphate or
sulfate).

Solid oral dosage form: 100 mg (as

doxycycline
hydrochloride or hyclate).
mefloquine Tablet: 250 mg (as hydrochloride).
proguanil Tablet: 100 mg (as hydrochloride).

sulfadoxine + pyrimethamine Tablet: 250 mg + 12.5 mg ; 500 mg + 25 mg.

6.5.4 Antipneumocystosis and

antitoxoplasmosis medicines
pyrimethamine Tablet: 25 mg.
sulfadiazine Tablet: 500 mg.

Injection:
80 mg + 16 mg/ mL in 5- mL ampoule; 80 mg +
16 mg/ mL in 10- mL ampoule.
sulfamethoxazole + trimethoprim
Oral liquid: 200 mg + 40 mg/5 mL .
Tablet: 100 mg + 20 mg; 400 mg + 80 mg ; 800
mg + 160 mg

pentamidine Tablet: 200 mg; 300 mg (as isethionate).

6.5.5 Antitrypanosomal medicines

6.5.5.1 African trypanosomiasis

fexinidazole Tablet: 600 mg
Medicines for the treatment of 1st stage
African trypanosomiasis
Powder for injection: 200 mg (as isetionate) in
pentamidine
vial.
suramin sodium Powder for injection: 1 g in vial.
Medicines for the treatment of 2nd stage
African trypanosomiasis
Injection: 200 mg (hydrochloride)/ mL in 100-
eflornithine
mL bottle.

Injection: 3.6% solution, 5- mL ampoule (180

melarsoprol
mg of active compound).

nifurtimox Tablet: 120 mg.

 Injection: 3.6% solution in 5- mL ampoule (180
melarsoprol
mg of active compound).

6.5.5.2 American trypanosomiasis

Tablet: 12.5 mg ;100 mg.

benznidazole
Tablet (scored): 50 mg.
nifurtimox Tablet: 30 mg; 120 mg; 250 mg.

6.6 Medicines for ectoparasitic infections

ivermectin Tablet (scored): 3 mg

7. ANTIMIGRAINE MEDICINES

7.1 For treatment of acute attack

acetylsalicylic acid Tablet: 300 mg to 500 mg.
ibuprofen Tablet: 200 mg; 400 mg.

Oral liquid: 120 mg/5 mL ; 125 mg/5 mL .

paracetamol
Tablet: 300 mg to 500 mg.

7.2 For prophylaxis

propranolol Tablet: 20 mg; 40 mg (hydrochloride).
metoprolol Tablet: 50 mg; 100 mg (tartrate).
8. IMMUNOMODULATORS AND
ANTINEOPLASTICS
8.1 Immunomodulators for non-malignant
disease

adalimumab Injection: 40 mg/0.8 mL; 40 mg/0.4 mL

certolizumab pegol Solution for injection: 200mg/ml

Pre-filled pen: 50mg
etanercept
Pre-filled syringe: 50mg

Suspension in a Pre-filled syringe: 100mg/ml

golimumab Suspension in a Prefilled pen: 100mg/ml
Solution in a Prefilled pen: 100mg/ml

Vial for injection: 100mg.

infliximab
Powder for solution for Injection: 100mg

Powder for injection: 100 mg (as sodium salt) in

azathioprine vial.
Tablet (scored): 50 mg.

Capsule: 25 mg.
ciclosporin Concentrate for injection: 50 mg/ mL in 1- mL
ampoule
8.2 Antineoplastics and supportive
medicines
8.2.1 Cytotoxic medicines

Concentrate for solution for infusion: 1 mg/mL

arsenic trioxide

asparaginase Powder for injection: 10 000 IU in vial.

bendamustine Injection: 45 mg/0.5 mL; 180 mg/2 mL.

bleomycin Powder for injection: 15 mg (as sulfate) in vial.

 Injection: 3 mg/ mL in 10- mL ampoule. Tablet:
calcium folinate
5 mg, 15 mg, 25 mg.
capecitabine Tablet: 150 mg; 500 mg.
Injection: 50 mg/5 mL; 150 mg/15 mL; 450
carboplatin
mg/45 mL; 600 mg/60 mL.
chlorambucil Tablet: 2 mg.

cisplatin Injection: 50 mg/50 mL; 100 mg/100 mL.

Powder for injection: 500 mg in vial. Tablet: 25

cyclophosphamide
mg, 50 mg.
cytarabine Powder for injection: 100 mg in vial.
dacarbazine Powder for injection: 100 mg in vial.

dactinomycin Powder for injection: 500 micrograms in vial.

Powder for injection: 50 mg (hydrochloride) in

daunorubicin
vial.
docetaxel Injection: 20 mg/ mL; 40 mg/ mL.
Powder for injection: 10 mg; 50 mg
doxorubicin
(hydrochloride) in vial.

Capsule: 50 mg, 100 mg.

etoposide
Injection: 20 mg/ mL in 5- mL ampoule.

Powder for injection: 50 mg (phosphate) in vial.

fludarabine
Tablet: 10 mg

fluorouracil Injection: 50 mg/ mL in 5- mL ampoule.

gemcitabine Powder for injection: 200 mg in vial, 1 g in vial.

Solid oral dosage form: 200 mg; 250 mg; 300

hydroxycarbamide mg; 400 mg; 500
mg; 1 g.
Powder for injection: 500 mg vial; 1-g vial; 2-g
ifosfamide
vial.

Injection: 40 mg/2 mL in 2- mL vial; 100 mg/5

irinotecan
mL in 5- mL vial; 500 mg/25 mL in 25- mL vial.

Tablet: 2 mg
melphalan
Powder for injection: 50 mg in vial
mercaptopurine Tablet: 50 mg.

Powder for injection: 50 mg (as sodium salt) in

methotrexate
vial. Tablet: 2.5 mg (as sodium salt).

Injection: 50 mg/10 mL in 10- mL vial; 100

mg/20 mL in 20- mL vial; 200 mg/40 mL in 40-
oxaliplatin
mL vial.
Powder for injection: 50 mg, 100 mg in vial.

paclitaxel Powder for injection: 6 mg/ mL.

pegaspargase Injection: 3,750 units/5 mL in vial.
procarbazine Capsule: 50 mg (as hydrochloride).
Tablet: 270 mg (containing tetra-arsenic tetra-
realgar-indigo naturalis formulation
sulfide 30 mg).
tioguanine Solid oral dosage form: 40 mg.

vinblastine Powder for injection: 10 mg (sulfate) in vial.

Powder for injection: 1 mg; 5 mg (sulfate) in

vincristine
vial.
Injection: 10 mg/mL in 1- mL vial; 50 mg/5
vinorelbine
mL in 5- mL vial.
8.2.2 Targeted therapies
all-trans retinoid acid (atra) Capsule: 10 mg.
bortezomib Powder for injection: 3.5 g in vial.
Tablet: 20 mg; 50 mg; 70 mg; 80 mg; 100 mg;
dasatinib
140 mg.
erlotinib Tablet: 100 mg, 150 mg
gefitinib Tablet: 250mg
afatinib Tablet: 20mg; 30mg; 40mg; 50mg
imatinib Tablet: 100 mg; 400 mg.
nilotinib Capsule: 150 mg; 200 mg.

Injection (intravenous): 100 mg/10 mL in 10-

rituximab
mL vial; 500 mg/50 mL in 50- mL vial.

Powder for injection: 60 mg; 150 mg; 440 mg in

trastuzumab
vial
8.2.3 Immunomodulators

Injection: 120 micrograms/0.2 mL; 300

micrograms/0.5 mL; 480 micrograms/0.8 mL in
filgrastim
pre-filled syringe 300 micrograms/mL in 1- mL
vial, 480 micrograms/1.6 mL in 1.6- mL vial.

lenalidomide Capsule: 25 mg

nivolumab Concentrate solution for infusion: 10 mg/mL

pembrolizumab Concentrate for solution for infusion: 25 mg/ml

thalidomide Capsule: 50 mg

8.2.4 Hormones and antihormones

abiraterone Tablet: 250 mg; 500 mg

anastrozole Tablet: 1 mg.
exemestane Tablet: 25 mg
letrozole Tablet: 2.5 mg
bicalutamide Tablet: 50 mg.
enzalutamide Capsule: 40mg

Injection: 4 mg/ mL in 1- mL ampoule (as

dexamethasone disodium phosphate salt).
Oral liquid: 2 mg/5 mL . Tablet: 2 mg ; 4 mg.

Powder for injection: 100 mg (as sodium

hydrocortisone
succinate) in vial.

leuprorelin Injection: 7.5 mg; 22.5 mg in pre-filled syringe

goserelin Injection: 3.6mg

triptorelin Injection: 0.1mg; 3.75mg

Injection: 40 mg/ mL (as sodium succinate) in 1-

mL single- dose vial and
methylprednisolone
5- mL multi-dose vials; 80 mg/ mL (as sodium
succinate) in 1- mL single-dose vial.

prednisolone Oral liquid: 5 mg/ mL . Tablet: 5 mg; 25 mg.

tamoxifen Tablet: 10 mg; 20 mg (as citrate).

8.2.5 Supportive medicines
allopurinol Tablet: 100 mg; 300 mg.
 Injection: 100 mg/ mL in 4- mL and 10- mL
mesna
ampoules. Tablet: 400 mg; 600 mg.

Concentrate solution for infusion: 4 mg/5 mL in

zoledronic acid 5- mL vial. Solution for infusion: 4 mg/100 mL
in 100- mL bottle.

9. ANTIPARKINSONISM
MEDICINES

Injection: 5 mg (lactate) in 1- mL ampoule.

biperiden
Tablet: 2 mg (hydrochloride).

Injection: 5 mg/ml
procyclidine
Tablet: 25 mg
Tablet: 100 mg + 10 mg; 100 mg + 25 mg; 250
levodopa + carbidopa
mg + 25 mg
10. MEDICINES AFFECTING THE
BLOOD
10.1 Antianaemia medicines
Oral liquid: equivalent to 25 mg iron (as sulfate)/
ferrous salt mL.
Tablet: equivalent to 60 mg iron.
Tablet: equivalent to 60 mg iron + 400
ferrous salt + folic acid
micrograms folic acid
folic acid Tablet: 400 micrograms; 1 mg; 5 mg.

Injection: 1 mg (as acetate, as hydrochloride or

hydroxocobalamin
as sulfate) in 1- mL ampoule.

Injection: pre-filled syringe

1000IU/ 0.5 mL; 2000IU/ 0.5 mL; 3000IU/ 0.3
erythropoiesis-stimulating agents mL; 4000IU/ 0.4 mL; 5000IU/ 0.5 mL; 6000IU/
0.6 mL; 8000IU/ 0.8mL; 10 000IU/ 1 mL; 20
000IU/ 0.5 mL; 40 000IU/ 1 mL

10.2 Medicines affecting coagulation

dabigatran Capsule: 110 mg; 150 mg

apixaban Tablet: 2.5 mg, 5 mg
edoxaban Tablet: 15 mg, 30 mg, 60 mg
rivaroxaban Tablet: 10 mg, 15 mg, 20 mg

Injection: ampoule or pre-filled syringe

20 mg/0.2 mL; 40 mg/0.4 mL; 60 mg/0.6 mL; 80
enoxaparin
mg/0.8 mL;
100 mg/1 mL; 120 mg/0.8 mL; 150 mg/1 mL

Injection: 1000 IU/ mL; 5000 IU/ mL; 20 000

heparin sodium
IU/ mL in 1- mL ampoule.

Injection: 1 mg/ mL ; 10 mg/ mL in ampoule.

phytomenadione
Tablet: 10 mg.

protamine sulfate Injection: 10 mg/ mL in 5- mL ampoule.

tranexamic acid Injection: 100 mg/ mL in 10- mL ampoule.

warfarin Tablet: 1 mg; 2 mg; 5 mg (sodium salt).

 Injection: 4 micrograms/ mL (as acetate) in 1-
mL ampoule.
desmopressin
Nasal spray: 10 micrograms (as acetate) per
dose

Injection: 1000 IU/ mL; 5000 IU/ mL in 1- mL

heparin sodium
ampoule.

protamine sulfate Injection: 10 mg/ mL in 5- mL ampoule.

warfarin Tablet: 0.5 mg; 1 mg; 2 mg; 5 mg (sodium salt).

10.3 Other medicines for

haemoglobinopathies

deferoxamine Powder for injection: 500 mg (mesilate) in vial.

hydroxycarbamide Solid oral dosage form: 200 mg; 500 mg; 1 g.

11. BLOOD PRODUCTS OF HUMAN

ORIGIN AND PLASMA
SUBSTITUTES
11.1 Blood and blood components
fresh–frozen plasma
platelets
red blood cells
whole blood
11.2 Plasma-derived medicines
11.2.1 Human immunoglobulins

anti-d immunoglobulin Injection: 250 micrograms in single-dose vial.

anti-rabies immunoglobulin Injection: 150 IU/ mL in vial.

anti-tetanus immunoglobulin Injection: 500 IU in vial.

Intramuscular administration: 16% protein

solution. Intravenous administration: 5%; 10%
normal immunoglobulin protein solution.
Subcutaneous administration: 15%; 16% protein
solution.

11.2.2 Blood coagulation factors

coagulation factor viii Powder for injection: 500 IU/vial.

coagulation factor ix Powder for injection: 500 IU/vial, 1000 IU/vial.

11.3 Plasma substitutes

Injectable solution: 6%.
dextran 70 * Polygeline, injectable solution, 3.5% is
considered as equivalent.
12. CARDIOVASCULAR
MEDICINES
12.1 Antianginal medicines
bisoprolol Tablet: 1.25 mg; 5 mg.
metoprolol Tablet: 50 mg; 100 mg

carvedilol Tablet: 3.125 mg; 6.25 mg; 12.5 mg; 25 mg

glyceryl trinitrate Tablet (sublingual): 500 micrograms.

isosorbide dinitrate Tablet (sublingual): 5 mg.
verapamil Tablet: 40 mg; 80 mg (hydrochloride).
12.2 Antiarrhythmic medicines
bisoprolol Tablet: 1.25 mg; 5 mg.
 metoprolol Tablet: 50 mg; 100 mg.

carvedilol Tablet: 3.125 mg; 6.25 mg; 12.5 mg; 25 mg.

Injection: 250 micrograms/ mL in 2- mL

digoxin ampoule. Oral liquid: 50 micrograms/ mL.
Tablet: 62.5 micrograms; 250 micrograms.

Injection: 100 micrograms/ mL (as acid tartrate

epinephrine (adrenaline)
or hydrochloride) in 10- mL ampoule.

Injection: 20 mg (hydrochloride)/ mL in 5- mL
lidocaine
ampoule.
Injection: 2.5 mg (hydrochloride)/ mL in 2- mL
verapamil ampoule.
Tablet: 40 mg; 80 mg (hydrochloride).

Injection: 50 mg/ mL in 3- mL ampoule

(hydrochloride).
amiodarone
Tablet: 100 mg; 200 mg; 400 mg
(hydrochloride).

12.3 Antihypertensive medicines

amlodipine Tablet: 5 mg (as maleate, mesylate or besylate).

felodipine Tablet: 5mg; 10mg

nifedipine Tablet: 20mg; 30mg; 60mg
bisoprolol Tablet: 1.25 mg; 5 mg.
atenolol Tablet: 25 mg; 50 mg; 100 mg
metoprolol Tablet: 50 mg; 100 mg (tartrate).

carvedilol Tablet: 3.125 mg; 6.25 mg; 12.5 mg; 25 mg

enalapril Tablet: 2.5 mg; 5 mg (as hydrogen maleate).

captopril Tablet: 25 mg; 50 mg.

lisinopril Tablet: 5 mg; 10 mg; 20 mg; 40 mg.
perindopril Tablet: 5 mg; 10 mg.
ramipril Tablet: 2.5 mg; 5 mg; 10 mg.
fosinopril Tablet: 10 mg; 20 mg; 40 mg.
imidapril Tablet: 5 mg; 10 mg.

Powder for injection: 20 mg (hydrochloride) in

hydralazine
ampoule. Tablet: 25 mg; 50 mg (hydrochloride).

Oral liquid: 50 mg/5 mL.

hydrochlorothiazide
Solid oral dosage form: 12.5 mg; 25 mg.

Tablet: 10 mg + 5 mg; 20 mg + 5 mg; 20 mg +

lisinopril + amlodipine
10 mg
Tablet: 10 mg + 10 mg; 10 mg + 5 mg; 5 mg +
perindopril + amlodipine
10 mg; 5mg + 5mg.
Tablet: 10 mg + 10 mg; 10 mg + 5 mg; 5 mg +
ramipril + amlodipine
10 mg; 5mg + 5mg.
Tablet: 10 mg + 12.5 mg; 20 mg + 12.5 mg; 20
lisinopril + hydrochlorothiazide
mg + 25 mg

enalapril + hydrochlorothiazide Tablet: 20mg + 12.5mg

perindopril + indapamide Tablet: 5mg + 1.25mg; 2.5mg + 0.625mg

 quinapril + hydrochlorothiazide Tablet: 20mg + 12.5mg

losartan Tablet: 25 mg; 50 mg; 100 mg.

eprosartan Tablet: 600mg
valsartan Tablet: 40mg; 80mg; 160mg; 320mg
irbesartan Tablet: 150mg; 300mg
methyldopa Tablet: 250 mg.
Tablet: 40 mg + 5 mg; 80 mg + 5 mg; 80 mg +
telmisartan + amlodipine
10 mg
Tablet: 10mg + 160mg; 5mg + 160mg; 5mg +
amlodipine + valsartan
320mg
amlodipine + candesartan Tablet: 2.5mg + 8mg; 5mg + 8mg
Tablet: 40 mg + 12.5 mg; 80 mg + 12.5 mg; 80
telmisartan + hydrochlorothiazide
mg + 25 mg
Tablet: 50 mg + 12.5 mg, 100 mg + 12.5 mg,
losartan + hydrochlorothiazide
100 mg + 25 mg.

eprosartan + hydrochlorothiazide Tablet: 600 + 12.5 mg

Tablet: 80 + 12.5 mg, 160 + 12.5 mg, 160 + 25

valsartan, hydrochlorothiazide
mg, 320 + 12.5 mg, 320 + 25 mg

Tablet: 150 mg + 12.5 mg, 300 mg + 12.5 mg,

irbesartan + hydrochlorothiazide
300 + 25 mg

candesartan + hydrochlorothiazide Tablet: 16mg + 12.5mg

Tablet: 20mg+12.5mg, 12.5mg+40mg,

olmesartan + hydrochlorothiazide
25mg+40mg

sodium nitroprusside Powder for infusion: 50 mg in ampoule.

12.4 Medicines used in heart failure

Tablet: 1.25 mg; 5 mg.

bisoprolol * includes metoprolol and carvedilol as
alternatives.
metoprolol Tablet: 50 mg; 100 mg

carvedilol Tablet: 3.125 mg; 6.25 mg; 12.5 mg; 25 mg

Injection: 250 micrograms/ mL in 2- mL

digoxin ampoule. Oral liquid: 50 micrograms/ mL.
Tablet: 62.5 micrograms; 250 micrograms.

enalapril Tablet: 2.5 mg; 5 mg (as hydrogen maleate).

captopril Tablet : 50mg, 25mg

fosinopril Tablet: 10mg , 20mg
lisinopril Tablet: 10mg, 20mg,5mg,40mg
perindopril Tablet: 5mg,10mg
quinapril Tblet: 10mg , 20mg
ramipril Tablet: 10mg,2.5mg,5mg

Injection: 10 mg/ mL in 2- mL ampoule.

furosemide Oral liquid: 20 mg/5 mL .
Tablet: 40 mg.

bumetanide Tablet: 1 mg.

Oral liquid: 50 mg/5 mL.
hydrochlorothiazide
Solid oral dosage form: 25 mg.
losartan Tablet: 25 mg; 50 mg; 100 mg
 valsartan Tablet: 40 mg , 80 mg, 160 mg, 320 mg

candesartan Tablet: 4 mg, 8 mg, 16 mg or 32

telmisartan Tablet: 20 mg, 40 mg or 80 mg
spironolactone Tablet: 25 mg.
Injection: 40 mg/ mL (hydrochloride) in 5- mL
dopamine
vial.
12.5 Antithrombotic medicines
12.5.1 Anti-platelet medicines
acetylsalicylic acid Tablet: 100 mg.
clopidogrel Tablet: 75 mg; 300 mg
12.5.2 Thrombolytic medicines

Powder for injection: 10 mg; 20 mg; 50 mg in

alteplase
vial

streptokinase Powder for injection: 1.5 million IU in vial.

12.6 Lipid-lowering agents

simvastatin Tablet: 5 mg; 10 mg; 20 mg; 40 mg.
fluvastatin Tablet: 80mg
atorvastatin Tablet: 10mg; 20mg; 40mg; 80mg
rosuvastatin Tablet: 5mg; 10mg; 20mg; 40mg;
pitavastatin Tablet: 2mg; 4mg
13. DERMATOLOGICAL
MEDICINES (topical)
13.1 Antifungal medicines
miconazole Cream or ointment: 2% (nitrate).
clotrimazole Cream: 1%
isoconazole Cream: 1%
ketoconazole Cream: 2%
sertaconazole Cream: 2%
selenium sulfide Detergent-based suspension: 2%.
sodium thiosulfate Solution: 15%.
Cream: 1% or Ointment: 1% terbinafine
terbinafine
hydrochloride.
13.2 Anti-infective medicines
Cream (as mupirocin calcium): 2%.
mupirocin
Ointment: 2%.
potassium permanganate Aqueous solution: 1:10 000.
silver sulfadiazine a Cream: 1%.
13.3 Anti-inflammatory and antipruritic
medicines
betamethasone Cream or ointment: 0.1% (as valerate).
mometasone Lotion, cream or ointment: 0.1%.
fluticasone propionate Ointment: 0.005%

methylprednisolone Cream or ointment: 0.1% (as aceponate)

calamine Lotion.
hydrocortisone Cream or ointment: 1% (acetate).
fluticasone propionate Cream: 0.05%
13.4 Medicines affecting skin
differentiation and proliferation
benzoyl peroxide Cream or lotion: 5%.
coal tar Solution: 5%.
fluorouracil Ointment: 5%.
 podophyllum resin Solution: 10% to 25%.
salicylic acid Solution: 5%.
urea Cream or ointment: 5%; 10%.
13.5 Scabicides and pediculicides
benzyl benzoate Lotion: 25%.

lindane Cream, cutaneous liquid, or shampoo: 1 /%

Cream: 5%.
permethrin
Lotion: 1%.
14. DIAGNOSTIC AGENTS
14.1 Ophthalmic medicines
fluorescein Eye drops: 1% (sodium salt).
tropicamide Eye drops: 0.5%.
atropine Eye drops: 0.5%; 1%
cyclopentolate Eye drops: 0.5%; 1%
homatropine Eye drops: 2%
14.2 radiocontrast media

Injection: 140 mg to 420 mg iodine (as sodium

amidotrizoate
or meglumine salt)/ mL in 20- mL ampoule.

barium sulfate Aqueous suspension.

Injection: 140 mg to 350 mg iodine/ mL in 5-

iohexol
mL; 10- mL; 20- mL ampoules.

Injection: 150 mg/ml, 200 mg/ml, 300 mg/ml,

iopamidol
370 mg/ml
iopromide Injection: 300 mg/mL and 370 mg/ml.
Injection: 160 mg/ml, 240 mg/ml, 300 mg/ml,
ioversol
320 mg/ml, 350 mg/m
Injection: 270 mg/ml, 305 mg/ml, 320 mg/ml,
iodixanol
550 mg/ml, 652 mg/m
iobitridol Injection: 300 mg/ml, 350 mg/ml.
barium sulfate Aqueous suspension.
Solution: 5 g to 8 g iodine in 100 mL to 250
meglumine iotroxate
mL.
15. DISINFECTANTS AND
ANTISEPTICS
15.1 Antiseptics
chlorhexidine Solution: 5% (digluconate).
ethanol Solution: 70% (denatured).
Solution: 10% (equivalent to 1% available
povidone iodine
iodine).
15.2 Disinfectants
Solution: containing ethanol 80% volume
alcohol based hand rub /volume Solution: containing isopropyl alcohol
75% volume/volume

chlorine base compound Powder: (0.1% available chlorine) for solution.

chloroxylenol Solution: 4.8%.

glutaral Solution: 2%.
16. DIURETICS
amiloride Tablet: 5 mg (hydrochloride).
Injection: 10 mg/ mL in 2- mL ampoule. Oral
furosemide liquid: 20 mg/5 mL.
Tablet: 10 mg ; 20 mg ; 40 mg.
bumetanide  Tablet: 1 mg.
 hydrochlorothiazide Solid oral dosage form: 25 mg.
mannitol Injectable solution: 10%; 20%.
spironolactone Tablet: 25 mg.
hydrochlorothiazide Tablet (scored): 25 mg.
mannitol Injectable solution: 10%; 20%.
Oral liquid: 5 mg/5 mL; 10 mg/5 mL; 25 mg/5
spironolactone mL.
Tablet: 25 mg.
17. GASTROINTESTINAL
MEDICINES

Age-appropriate formulations and doses

pancreatic enzymes
including lipase, protease and amylase.

17.1 Antiulcer medicines

Powder for injection: 40 mg in vial

omeprazole Powder for oral liquid: 20 mg; 40 mg sachets.
Solid oral dosage form: 10 mg; 20 mg; 40 mg.

pantoprazole Tablet: 20mg; 40mg.

lansoprazole Capsule: 15mg; 30mg.
rabeprazole Tablet: 10mg; 20mg.
Tablet: 20mg; 40mg.
esomeprzole
Injectable: 40mg.
dexlansoprazole Capsule: 30mg; 60mg.

Injection: 25 mg/ mL (as hydrochloride) in 2-

mL ampoule.
ranitidine
Oral liquid: 75 mg/5 mL (as hydrochloride).
Tablet: 150 mg (as hydrochloride).

Tablet: 200mg.
cimetidine
Oral liquid: 40 mg/ml.
nizatidine Capsule: 75mg; 150mg; 300mg.
17.2 Antiemetic medicines

Injection: 4 mg/ mL in 1- mL ampoule (as

disodium phosphate salt).
dexamethasone Oral liquid: 0.5 mg/5 mL; 2 mg/5 mL.
Solid oral dosage form: 0.5 mg; 0.75 mg; 1.5
mg; 4 mg.

Injection: 5 mg (hydrochloride)/ mL in 2- mL
ampoule.
metoclopramide
Oral liquid: 5 mg/5 mL .
Tablet: 10 mg (hydrochloride).

Injection: 2 mg base/ mL in 2- mL ampoule (as

hydrochloride). Oral liquid: 4 mg base/5 mL.
ondansetron
Solid oral dosage form: Eq 4 mg base; Eq 8 mg
base; Eq 24 mg base.

palonosetron Injection: 0.05 mg/ml.

granisetron Injection: 1 mg/ml.

Capsule: 80 mg; 125 mg; 165 mg

aprepitant
Powder for oral susupension: 125 mg in sachet

17.3 Anti-inflammatory medicines

Retention enema. Suppository: 500 mg.

sulfasalazine
Tablet: 500 mg.
 Tablet: 1 g, 500 mg
Suppository:1g, 500mg
mesalazine Enema: 1g, 4g
Granules:1g
Oral powder: 2g

Retention enema.
hydrocortisone
Suppository: 25 mg (acetate).
17.4 Laxatives
Tablet: 7.5 mg (sennosides) (or traditional
senna
dosage forms).
17.5 Medicines used in diarrhoea
Co-package containing:
ORS powder for dilution (see Section 17.5.1) –
oral rehydration salts – zinc sulfate
zinc sulfate solid oral dosage form 20 mg (see
Section 17.5.2)
17.5.1 Oral rehydration

oral rehydration salts Powder for dilution in 200 mL; 500 mL; 1 L.

glucose: 75 mEq
sodium: 75 mEq or
mmol/L
chloride: 65 mEq or
mmol/L
potassium: 20 mEq or
mmol/L
citrate: 10 mmol/L
osmolarity: 245 mOsm/L
glucose: 13.5 g/L
sodium chloride: 2.6 g/L potassium
chloride: 1.5 g/L trisodium citrate
dihydrate*: 2.9 g/L
*trisodium citrate dihydrate may be replaced by
sodium hydrogen carbonate (sodium
bicarbonate) 2.5 g/L. However, as the stability
of this latter formulation is very poor under
tropical conditions, it is recommended only
when manufactured for immediate use.

17.5.2 Medicines for diarrhoea

zinc sulfate Solid oral dosage form: 20 mg.
18. MEDICINES FOR ENDOCRINE
DISORDERS
18.1 Adrenal hormones and synthetic
substitutes
fludrocortisone Tablet: 100 micrograms (acetate).
hydrocortisone Tablet: 5 mg; 10 mg; 20 mg.
18.2 Androgens

testosterone Injection: 200 mg (enanthate) in 1- mL ampoule.

18.3 Estrogens
18.4 Progestogens

medroxyprogesterone acetate Tablet: 5 mg.

norethisterone Tablet: 5 mg
18.5 Medicines for diabetes
18.5.1 Insulins
Injection: 40 IU/ mL in 10- mL vial; 100 IU/ mL
insulin injection (soluble)
in 10- mL vial.

Injection: 40 IU/ mL in 10- mL vial; 100 IU/ mL

intermediate-acting insulin in 10- mL vial (as compound insulin zinc
suspension or isophane insulin).

18.5.2 Oral hypoglycaemic agents

Solid oral dosage form: (controlled-release

gliclazide
tablets) 30 mg; 60 mg; 80 mg.

glibenclamide Tablet: 5 mg
glipizide Tablet: 5 mg
glimepiride Tablet: 1 mg, 2 mg, 3 mg, 4 mg, 6 mg.
metformin Tablet: 500 mg (hydrochloride).
metformin Tablet: 500 mg (hydrochloride).

18.6 medicines for hypoglycaemia

glucagon Injection: 1 mg/ mL.

Oral liquid: 50 mg/mL.
diazoxide
Tablet: 50 mg.
18.7 thyroid hormones and antithyroid
medicines

Tablet: 25 micrograms ; 50 micrograms; 100

levothyroxine
micrograms (sodium salt).

potassium iodide Tablet: 60 mg.

methimazole Tablet: 5mg, 10mg, 20mg.
carbimazole Tablet: 5mg
propylthiouracil Tablet: 50 mg.

lugol's solution Oral liquid: about 130 mg total iodine/ mL.

methimazole Tablet: 5mg, 10mg, 20mg.

potassium iodide Tablet: 60 mg.
propylthiouracil Tablet: 50 mg.
19. IMMUNOLOGICALS
19.1 Diagnostic agents
tuberculin, purified protein
Injection.
derivative (ppd)
19.2 sera and immunoglobulins
anti-venom immunoglobulin Injection.

diphtheria antitoxin Injection: 10 000 IU; 20 000 IU in vial.

19.3 vaccines
Recommendations for all
BCG vaccine
diphtheria vaccine
haemophilus influenzae type B
vaccine
hepatitis b vaccine
HPV vaccine
measles vaccine
pertussis vaccine
pneumococcal vaccine
 poliomyelitis vaccine
rotavirus vaccine
rubella vaccine
tetanus vaccine

Recommendations for certain regions

japanese encephalitis vaccine

yellow fever vaccine

tick-borne encephalitis vaccine

Recommendations for some high-risk

populations
cholera vaccine
dengue vaccine
hepatitis A vaccine

meningococcal meningitis vaccine

rabies vaccine
typhoid vaccine

Recommendations for immunization

programmes with certain characteristics

influenza vaccine (seasonal)

mumps vaccine
varicella vaccine

20. MUSCLE RELAXANTS

(PERIPHERALLY-ACTING) AND
CHOLINESTERASE INHIBITORS

Injection: 500 micrograms in 1- mL ampoule;

neostigmine 2.5 mg (metilsulfate) in 1- mL ampoule.
Tablet: 15 mg (bromide).

Injection: 50 mg (chloride)/ mL in 2- mL
suxamethonium ampoule.
Powder for injection (chloride), in vial.
atracurium Injection: 10 mg/ mL (besylate).

vecuronium Powder for injection: 10 mg (bromide) in vial.

suxamethonium Injection: 50 mg/ml.

pancuronium Injection: 2 mg/ml.

atracurium Injection: 2 mg/ml, 5 mg/ml, 10 mg/ml.

rocuronium Injection: 10 mg/ml.

mivacurium Injection: 2 mg/ml.
cisatracurium Injection: 2 mg/ml, 5 mg/ml.
Injection: 1 mg in 1- mL ampoule.
pyridostigmine
Tablet: 60 mg (bromide).

vecuronium Powder for injection: 10 mg (bromide) in vial.

suxamethonium Injection: 50 mg/ml.

pancuronium Injection: 2 mg/ml.

atracurium Injection: 2 mg/ml, 5 mg/ml, 10 mg/ml.

rocuronium Injection: 10 mg/ml.

mivacurium Injection: 2 mg/ml.
cisatracurium Injection: 2 mg/ml, 5 mg/ml.
21. OPHTHALMOLOGICAL
PREPARATIONS
21.1 Anti-infective agents
aciclovir Ointment: 3% W/W.
azithromycin Solution (eye drops): 1.5%.
erythromycin Ointment: 0.5%.
gentamicin Solution (eye drops): 0.3% (sulfate).
Eye drops: 0.3%
tobramycin
Eye ointment: 0.3%
natamycin Suspension: (eye drops): 5%
ofloxacin Solution (eye drops): 0.3%.
norfloxacin  Eye drop: 0.3%.
ciprofloxacin Eye ointment: 0.3%.
moxifloxacin  Eye drops solutions: 0.5%.
gatifloxacin  Eye drops solution: 0.3% , 0.5%.
tetracycline Eye ointment: 1% (hydrochloride).
21.2 Anti-inflammatory agents

prednisolone Solution (eye drops): 0.5% (sodium phosphate).

hydrocortisone Eye ointment: 0.1%.

fluorometholone Eye drops, suspension: 0.1%
clobetasone Eye drops: 0.1%
21.3 Local anaesthetics

tetracaine Solution (eye drops): 0.5% (hydrochloride).

lidocaine hydrochloride and
Eye drops: 0.25%,4%
fluorescein
oxybuprocaine  Eye drop solution: 0.4%

21.4 Miotics and antiglaucoma medicines

acetazolamide Tablet: 250 mg.

Solution (eye drops): latanoprost 50
latanoprost
micrograms/mL.
Solution (eye drops): 2%; 4% (hydrochloride or
pilocarpine
nitrate).
Solution (eye drops): 0.25%; 0.5% (as hydrogen
timolol
maleate).
betaxolol Solution (eye drops): 0.5%
levobunolol Solution (eye drops): 0.5%
carteolol Solution (eye drops): 1%, 2%
21.5 Mydriatics

atropine Solution (eye drops): 0.1%; 0.5%; 1% (sulfate).

homatropine Solution (eye drops): 0.5%; 2%

cyclopentolate Solution (eye drops): 0.5%; 1%; 2%

epinephrine (adrenaline) Solution (eye drops): 2% (as hydrochloride).

21.6 Anti-vascular endothelial growth

factor (VEGF) preparations

bevacizumab Injection: 25 mg/ mL.

22. MEDICINES FOR
REPRODUCTIVE HEALTH AND
PERINATAL CARE
22.1 Contraceptives
22.1.1 Oral hormonal contraceptives

ethinylestradiol + levonorgestrel Tablet: 30 micrograms + 150 micrograms.

ethinylestradiol + norethisterone Tablet: 35 micrograms + 1 mg.

ethinylstradiol + norgestimate Tablet: 35 micrograms + 250 micrograms

Tablet: 30 micrograms + 75 micrograms; 15

ethinylstradiol + gestodene
micrograms + 60 micrograms

Tablet: 35 micrograms + 250 micrograms + 30

ethinylstradiol + desogestrel
micrograms + 150 micrograms

ethinylestradiol + drospirenone Tablet: 30 micrograms + 3 mg

Tablet: 30 micrograms; 750 micrograms (pack

levonorgestrel
of two); 1.5 mg.
ulipristal Tablet: 30 mg (as acetate)

22.1.2 Injectable hormonal contraceptives

estradiol cypionate +
Injection: 5 mg + 25 mg.
medroxyprogesterone acetate

Injection (intramuscular): 150 mg/ mL in 1- mL

vial.
medroxyprogesterone acetate Injection (subcutaneous): 104 mg/0.65 mL in
pre-filled syringe or single-dose injection
delivery system.

norethisterone enantate Oily solution: 200 mg/ mL in 1- mL ampoule.

22.1.3 Intrauterine devices

copper-containing device
levonorgestrel-releasing intrauterine Intrauterine system with reservoir containing 52
system mg of levonorestrel
22.1.4 Barrier methods
condoms
diaphragms

22.1.5 Implantable contraceptives

Single-rod etonogestrel-releasing implant,

etonogestrel-releasing implant
containing 68 mg of etonogestrel.

Two-rod levonorgestrel-releasing implant, each

levonorgestrel-releasing implant rod containing 75 mg of levonorgestrel (150 mg
total).

22.1.6 Intravaginal contraceptives

Progesterone-releasing vaginal ring containing

progesterone vaginal ring
2.074 g of micronized progesterone.

22.2 Ovulation inducers

clomifene Tablet: 50 mg (citrate).
22.3 Uterotonics

carbetocin Injection (heat stable): 100 micrograms/mL

Injection: 200 micrograms (hydrogen maleate)

ergometrine
in 1- mL ampoule.
Tablet: 0.125mg
methylergometrine
Injection:0.2mg/ml
 Tablet 200 mg – tablet 200 micrograms. Co-
package containing:
mifepristone – misoprostol mifepristone 200 mg tablet [1] and misoprostol
200 microgram
tablet [4]

Tablet: 200 micrograms.

misoprostol
Vaginal tablet: 25 micrograms.
oxytocin Injection: 10 IU in 1- mL.
22.4 Antioxytocics (tocolytics)
nifedipine Immediate-release capsule: 10 mg.
22.5 Other medicines administered to the
mother
Injection: 4 mg/ mL dexamethasone phosphate
dexamethasone
(as disodium salt)

tranexamic acid Injection: 100 mg/mL in 10-mL ampoule

22.6 Medicines administered to the

neonate

Injection: 20 mg/ mL (equivalent to 10 mg

caffeine base/ mL).
caffeine citrate
Oral liquid: 20 mg/ mL (equivalent to 10 mg
caffeine base/ mL).

Solution or gel: 7.1% (digluconate) delivering

chlorhexidine
4% chlorhexidine (for umbilical cord care).

ibuprofen Solution for injection: 5 mg/ mL.

Solution for injection:

prostaglandin Prostaglandin E1: 0.5 mg/ mL in alcohol.
Prostaglandin E 2: 1 mg/ mL.

Suspension for intratracheal instillation: 25 mg/

surfactant
mL or 80 mg/ mL.
23. PERITONEAL DIALYSIS
SOLUTION

intraperitoneal dialysis solution (of

Parenteral solution.
appropriate composition)

24. MEDICINES FOR MENTAL AND

BEHAVIOURAL DISORDERS

24.1 Medicines used in psychotic

disorders

Injection: 25 mg (hydrochloride)/ mL in 2- mL
ampoule. Oral liquid: 25 mg (hydrochloride)/5
chlorpromazine
mL.
Tablet: 100 mg (hydrochloride).

Injection: 25 mg (decanoate or enantate) in 1-

fluphenazine
mL ampoule.
trifluoperazine Tablet: 1mg; 5mg
Injection: 5 mg in 1- mL ampoule.
haloperidol
Tablet: 2 mg; 5 mg.
droperidol Injection: 1.25 mg/ml

risperidone Solid oral dosage form: 0.25 mg to 6.0 mg.

 Injection: 25 mg (hydrochloride)/ mL in 2- mL
ampoule. Oral liquid: 25 mg (hydrochloride)/5
chlorpromazine mL.
Tablet: 10 mg; 25 mg; 50 mg; 100 mg
(hydrochloride).

clozapine Solid oral dosage form: 25 to 200 mg.

Injection: 5 mg in 1- mL ampoule. Oral liquid: 2

haloperidol mg/ mL.
Solid oral dosage form: 0.5 mg; 2 mg; 5 mg.

24.2 Medicines used in mood disorders

24.2.1 Medicines used in depressive

disorders
amitriptyline Tablet: 25 mg; 75mg. (hydrochloride).
imipramine  Tablet:10mg, 25mg
maprotiline  Tablet; 25mg , 50mg
Capsule : 25mg
dosulepin
Tablet:75mg
clomipramine  Tablet: 10mg, 25mg
Solid oral dosage form: 20 mg (as
fluoxetine
hydrochloride).
sertraline  Tablet: 50 mg;100 mg
Tablet: 10 mg; 12.5 mg; 20 mg; 40 mg; 25 mg;
paroxetine 
30 mg
citalopram  Tablet: 20 mg; 40 mg.
fluvoxamine  Tablet: 50mg; 100mg
escitalopram  Tablet: 5 mg; 10 mg; 15 mg; 20 mg
Solid oral dosage form: 20 mg (as
fluoxetine
hydrochloride).
24.2.2 Medicines used in bipolar
disorders
carbamazepine Tablet (scored): 100 mg; 200 mg.
lithium carbonate Solid oral dosage form: 300 mg.
Tablet (enteric-coated): 200 mg; 500 mg
valproic acid (sodium valproate)
(sodium valproate).

24.3 Medicines for anxiety disorders

diazepam Tablet (scored): 2 mg; 5 mg.

potassium clorazepate Capsule: 5mg; 10mg
lorazepam Tablet: 1mg; 2mg
bromazepam Tablet: 3mg
clobazam Oral suspension: 1mg/ml; 2mg/ml
alprazolam Tablet: 0.25mh; 0.5mg/ 1mg
24.4 Medicines used for obsessive
compulsive disorders

clomipramine Capsule: 10 mg; 25 mg (hydrochloride).

24.5 Medicines for disorders due to

psychoactive substance use

Chewing gum: 2 mg; 4 mg (as polacrilex).

nicotine replacement therapy (NRT) Transdermal patch: 5 mg to 30 mg/16 hrs; 7 mg
to 21 mg/24 hrs.

Concentrate for oral liquid: 5 mg/ mL; 10 mg/

mL (hydrochloride).
methadone
Oral liquid: 5 mg/5 mL; 10 mg/5 mL
(hydrochloride).
 buprenorphine Transdermal patch: 5 mg, 10 mg, 20 mg

25. MEDICINES ACTING ON THE

RESPIRATORY TRACT
25.1 Antiasthmatic medicines and
medicines for chronic obstructive
pulmonary disease

Inhalation (aerosol): 50 micrograms

beclometasone (dipropionate) per dose; 100 micrograms
(dipropionate) per dose (as CFC free forms).

Inhalation (aerosol): 100 micrograms per dose;

budesonide
200 micrograms per dose.

Nebuliser solution: 1000 micrograms per ml,

250 micrograms per ml
Dry powder inhaler: 50 micrograms per dose,
fluticasone 100 micrograms per dose, 250 micrograms per
dose, 500 micrograms per dose
Inhalation solution: 50 micrograms per dose,
250 micrograms per dose

Inhalation powder: 80 micrograms per dose, 160

ciclesonide
micrograms per dose
Dry powder inhaler: 100 micrograms + 6
budesonide + formoterol micrograms per dose; 200 micrograms + 6
micrograms per dose

Dry powder inhaler: 100 micrograms + 50

micrograms; 250 micrograms + 50 micrograms;
500 micrograms fluticasone + 50 mcg.
fluticasone + salmeterol
Pressurised inhalation, solution: 50 micrograms
+ 25 micrograms; 125 micrograms + 25
micrograms; 250 micrograms + 25 micrograms;

Dry powder inhaler: 100 micrograms + 6

beclomethasone + formoterol
micrograms; 200 micrograms + 12 micrograms.

Injection: 1 mg (as hydrochloride or hydrogen

epinephrine (adrenaline)
tartrate) in 1- mL ampoule.
Inhalation (aerosol): 20 micrograms/metered
ipratropium bromide
dose.

Inhalation (aerosol): 100 micrograms (as sulfate)

per dose.
Injection: 50 micrograms (as sulfate)/ mL in 5-
mL ampoule.
salbutamol
Metered dose inhaler (aerosol): 100 micrograms
(as sulfate) per dose.
Respirator solution for use in nebulizers: 5 mg
(as sulfate)/ mL.

Solution for injection: 0.5 mg/ml

Nebuliser solution: 2.5 mg/ml
terbutaline
Inhalation powder: 0.5 mg
Syrup: 0.3 mg/ml

Powder for inhalaton, capsule: 18 micrograms

tiotropium Inhalation solution: 1.25 micrograms; 2.5
micrograms per actuation

aclidinium bromide Inhalation: 322mcg, 340mcg/12mcg

umeclidinium bromide Inhalation : 62.5mcg
26. SOLUTIONS CORRECTING
WATER, ELECTROLYTE AND
ACID–BASE DISTURBANCES

26.1 Oral
oral rehydration salts See section 17.5.1.
potassium chloride Powder for solution.
26.2 Parenteral
Injectable solution: 5% (isotonic); 10%
glucose (hypertonic);
50% (hypertonic).

Injectable solution: 4% glucose, 0.18% sodium

chloride (equivalent to Na+ 30 mmol/L, Cl- 30
mmol/L).
Injectable solution: 5% glucose, 0.9% sodium
glucose with sodium chloride
chloride (equivalent to Na+ 150 mmol/L and Cl-
150 mmol/L); 5% glucose, 0.45% sodium
chloride (equivalent to Na+ 75 mmol/L and Cl-
75 mmol/L) .

Solution: 11.2% in 20- mL ampoule

(equivalent to K+ 1.5 mmol/ mL, Cl- 1.5 mmol/
mL).
potassium chloride Solution for dilution: 7.5% (equivalent to K 1
mmol/ mL and Cl 1 mmol/ mL) ; 15%
(equivalent to K 2 mmol/ mL and Cl
2 mmol/ mL) .

Injectable solution: 0.9% isotonic (equivalent to

sodium chloride
Na+ 154 mmol/L, Cl- 154 mmol/L).

Injectable solution: 1.4% isotonic (equivalent to

Na+ 167 mmol/L, HCO3- 167 mmol/L).
sodium hydrogen carbonate
Solution: 8.4% in 10- mL ampoule (equivalent
to Na+ 1000 mmol/L, HCO3-1000 mmol/L).

sodium lactate, compound solution Injectable solution.

26.3 Miscellaneous
water for injection 2- mL; 5- mL; 10- mL ampoules.

27. VITAMINS AND MINERALS

ascorbic acid Tablet: 50 mg.

calcium Tablet: 500 mg (elemental).

Oral liquid: 400 IU/ mL.

colecalciferol
Solid oral dosage form: 400 IU; 1000 IU.

Oral liquid: 250 micrograms/ mL (10 000 IU/

ergocalciferol mL).
Solid oral dosage form: 1.25 mg (50 000 IU).

Capsule: 190 mg.

Iodized oil: 1 mL (480 mg iodine); 0.5 mL (240
iodine
mg iodine) in ampoule (oral or injectable); 0.57
mL (308 mg iodine) in dispenser bottle.
 Sachets containing:
- iron (elemental) 12.5 mg (as coated ferrous
fumarate)
multiple micronutrient powder - zinc (elemental) 5 mg
- vitamin A 300 micrograms
- with or without other micronutrients at
recommended daily values

nicotinamide Tablet: 50 mg.

pyridoxine Tablet: 25 mg (hydrochloride).

Capsule: 50 000 IU; 100 000 IU; 200 000 IU (as

palmitate).
Oral oily solution: 100 000 IU (as palmitate)/
retinol mL in multidose dispenser.
Tablet (sugar-coated): 10 000 IU (as palmitate).
Water-miscible injection: 100 000 IU (as
palmitate) in 2- mL ampoule.

riboflavin Tablet: 5 mg.

sodium fluoride In any appropriate topical formulation.

thiamine Tablet: 50 mg (hydrochloride).

calcium gluconate Injection: 100 mg/ mL in 10- mL ampoule.

28. EAR, NOSE AND THROAT

MEDICINES
acetic acid Topical: 2%, in alcohol.
budesonide Nasal spray: 100 micrograms per dose.
fluticasone Nasal spray: 0.05%
mometasone Nasal spray: 0.05%
triamcinolone Nasal spray: 55 mcg

ciprofloxacin Topical: 0.3% drops (as hydrochloride).

chloramphenicol Topical: 5%
tetracycline Topical: 1%
gentamicin Topical: 0.3%
xylometazoline Nasal spray: 0.05%.
naphazoline Ear drops: 0.1%
29. MEDICINES FOR DISEASES OF
JOINTS
29.1 Medicines used to treat gout
allopurinol Tablet: 100 mg.

29.2 Disease-modifying agents used in

rheumatoid disorders (DMARDs)

Tablet: 100 mg; 150 mg (as phosphate or

chloroquine
sulfate).
azathioprine Tablet: 50 mg.

hydroxychloroquine Solid oral dosage form: 200 mg (as sulfate).

methotrexate Tablet: 2.5 mg (as sodium salt).

penicillamine Solid oral dosage form: 250 mg.
sulfasalazine Tablet: 500 mg.
29.3 Juvenile joint diseases
Suppository: 50 mg to 150 mg.
acetylsalicylic acid
Tablet: 100 mg to 500 mg.
 Alternatives [AL] [WHO
Complementary List [CL]
AL]

[AL]
[AL]

[WHO AL]

[WHO AL]

[AL]
[AL]
[AL]

[CL]

[WHO AL]

[AL]

[AL]
[WHO AL]

[AL]

[AL]

[CL]
[WHO AL]

[AL]
[AL]

[WHO AL]

[AL]

[AL]
[AL]
[AL]

[WHO AL]

[AL]

[AL]

[AL]
 [CL]

[CL]

[CL]

[CL]

[CL]

[WHO AL]
[CL]

[CL]

[CL]
[WHO AL]

[AL]
[CL]

[CL]

[CL]
[CL]

[CL]

[CL]

[CL]

[CL]
[CL]

[CL]

[CL]

[CL]

[CL]
 [CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[WHO AL]

[AL]
[AL]
 [CL]

[CL]

[AL]

[AL]
[AL]
[AL]

[CL]
[WHO AL]

[AL]
[AL]
[AL]
[CL]
 [CL]

[WHO AL]
[AL]

[WHO AL] [CL]

[AL] [CL]

[AL] [CL]

[AL] [CL]

[AL] [CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]
[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]
[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]

[CL]
[CL]
[CL]

[CL]

[CL]

[CL]

[CL]

[CL]
 [CL]
[CL]

[CL]

[WHO AL] [CL]

[AL] [CL]
[AL] [CL]
[CL]
[CL]

[CL]

[CL]

[CL]

[CL]

[WHO AL] [CL]

[AL] [CL]

[CL]

[CL]
[WHO AL] [CL]
[AL] [CL]
[AL] [CL]
[WHO AL] [CL]
[AL] [CL]

[CL]

[CL]

[WHO AL] [CL]

[AL] [CL]
[AL] [CL]

[CL]

[WHO AL] [CL]

[CL]

[CL]
 [CL]

[CL]

[WHO AL]

[AL]

[WHO AL] [CL]

[WHO AL]
[AL]
[AL]
[AL]

[WHO AL]

[WHO AL]
 [CL]

[CL]

[CL]

[WHO AL] [CL]

[CL]

[CL]

[CL]

[WHO AL] [CL]

[WHO AL] [CL]

[WHO AL]

[WHO AL]
[AL]

[AL]

[WHO AL]

[WHO AL]
[AL]

[AL]

[CL]

[WHO AL]

[AL]
[AL]
[WHO AL]
[AL]
[AL]

[AL]

[WHO AL]

[AL]
[AL]
[AL]
[AL]
[AL]
[AL]

[WHO AL]

[WHO AL]

[AL]

[AL]

[WHO AL]

[AL]

[AL]
[AL]

[WHO AL]
[AL]
[AL]
[AL]

[WHO AL]

[AL]

[AL]

[WHO AL]

[AL]

[AL]

[AL]

[AL]

[AL]

[AL]

[CL]

[WHO AL]

[AL]

[AL]

[WHO AL]

[AL]
[AL]
[AL]
[AL]
[AL]
[AL]

[WHO AL]

[AL]

[WHO AL]

[WHO AL]
[AL]

[AL]
[AL]

[CL]

[CL]

[CL]

[WHO AL]
[AL]
[AL]
[AL]
[AL]

[WHO AL]
[AL]
[AL]
[AL]
[AL]

[WHO AL]
[AL]
[AL]

[AL]

[WHO AL]
[WHO AL]
[AL]
[WHO AL]

[WHO AL]

[AL]

[WHO AL]
[AL]
[AL]
[AL]

[WHO AL]

[WHO AL]

[AL]

[AL]

[AL]

[AL]

[CL]

[WHO AL] [CL]

[WHO AL]
[WHO AL]

[WHO AL]

[WHO AL]

[WHO AL]

[WHO AL]

[AL]
[WHO AL]

[WHO AL] [CL]

[CL]

[CL]

[WHO AL] [CL]

[WHO AL]

[AL]
[AL]
[AL]

[AL]

[AL]

[WHO AL]

[AL]

[AL]

[WHO AL]

[AL]
[AL]

[CL]

[WHO AL]
[AL]

[WHO AL] [CL]

[WHO AL]

[CL]

[WHO AL]

[AL]
[WHO AL]

[AL]
[AL]
[AL]

[CL]

[CL]

[WHO AL]
[AL]

[CL]

[CL]
[CL]
[CL]
[WHO AL]

[WHO AL]

[AL]
[AL]

[AL]

[AL]
[AL]
[AL]

[CL]

[WHO AL] [CL]

[AL] [CL]
[AL] [CL]

[AL] [CL]

[AL] [CL]
[AL] [CL]
[AL] [CL]
[WHO AL]

[AL]

[WHO AL]
[AL]
[AL]
[AL]
[AL]

[WHO AL]

[AL]
[AL]
[AL]

[WHO AL]

[AL]

[AL]

[WHO AL]

[WHO AL]

[AL]
[AL]
[AL]

[WHO AL]

[AL] [CL]
[AL] [CL]

[CL]

[CL]
[WHO AL]

[WHO AL]

[AL]

[AL]

[AL]

[AL]

[CL]

[WHO AL]

[AL]
[WHO AL] [CL]

[WHO AL] [CL]

[CL]

[WHO AL]

[WHO AL]

[AL]

[WHO AL]

[AL]
 [CL]

[CL]

[CL]

[WHO AL]
[AL]
[AL]

[AL]

[AL]

[WHO AL]

[AL]

[AL]

[AL]
[AL]
[AL]

[CL]

[WHO AL]
[AL]
[AL]
[AL]
[AL]
[AL]

[WHO AL] [CL]

[AL] [CL]

[WHO AL]

[WHO AL]

[AL]

[AL]

[WHO AL]

[AL]

[AL]

[WHO AL]

[AL]

[WHO AL]

[AL]
[AL]
[WHO AL]

[WHO AL]
[WHO AL]

[CL]

[WHO AL]
[AL]
[AL]
[AL]

[WHO AL]

[AL]
[AL]
[AL]
[WHO AL]
[AL]

[CL]

[CL]

[CL]
[CL]
[CL]